Meridian Bioscience financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$79.61M $92.97M $108.41M $122.96M $139.64M $148.27M $143.00M $158.84M $172.71M $187.39M $187.08M $192.93M $196.08M $200.77M $213.57M $201.01M $253.67M $317.90M $333.02M $0.00M $0.00M
GM % Gross Margin %
57.35% 59.04% 59.66% 60.95% 61.93% 62.35% 62.19% 62.28% 63.14% 64.60% 62.67% 63.17% 64.88% 61.91% 61.35% 59.06% 61.60% 63.27% 56.56% 0.00% 0.00%
OM Operating Margin
18.41% 21.86% 25.57% 28.49% 31.76% 32.90% 29.80% 26.65% 29.13% 30.59% 28.00% 29.06% 27.30% 22.30% 20.90% 19.37% 24.32% 31.74% 22.70% 0.00% 0.00%
EPS Earnings Per Share
$0.00 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0m 33.94m 39.09m 39.32m 39.95m 40.32m 40.5m 40.94m 41.24m 41.31m 41.53m 41.67m 42.04m 42.2m 42.31m 42.46m 42.83m 43.12m 43.51m 43.83m 0m
OCF Operating Cash Flow
$12.65M $18.19M $22.16M $26.60M $29.88M $32.49M $29.73M $22.46M $42.45M $44.44M $38.26M $42.81M $37.22M $41.36M $34.79M $36.18M $47.98M $66.87M $82.36M $0.00M $0.00M
FCF Free Cash Flow
$10.26M $15.60M $19.04M $23.39M $25.66M $28.85M $26.65M $-17.63M $7.69M $41.20M $32.96M $38.20M $33.22M $36.89M $30.58M $32.03M $44.68M $48.56M $73.74M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$0.30 $0.44 $0.48 $0.58 $0.61 $0.71 $0.65 $0.33 $0.92 $1.00 $0.75 $0.91 $0.79 $0.87 $0.72 $0.76 $1.04 $1.12 $1.69 $0.00 $0.00